|
|
Volumn 10, Issue 6, 2014, Pages 1427-1430
|
|
Human vaccines & immunotherapeutics: News
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIALLERGIC AGENT;
DENGUE VACCINE;
DPX SURVIVAC;
GRASTEK;
IMMUNOMODULATING AGENT;
MENINGOCOCCUS VACCINE;
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS VACCINE;
ORALAIR;
RAGWITEK;
SL 701 VACCINE;
TUMOR VACCINE;
TUMOR VACCINE IMA950;
UNCLASSIFIED DRUG;
VIRUS VACCINE;
BRAIN CANCER;
DENGUE;
DISEASE SURVEILLANCE;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG SAFETY;
GEOGRAPHIC DISTRIBUTION;
GLIOBLASTOMA;
HAY FEVER;
HUMAN;
IMMUNOGENICITY;
IMMUNOMODULATION;
IMMUNOTHERAPY;
INDONESIA;
MALAYSIA;
MENINGOCOCCOSIS;
MORBIDITY;
MORTALITY;
NONHUMAN;
NOTE;
PERTUSSIS;
PHILIPPINES;
POLLEN ALLERGY;
SEVERE ACUTE RESPIRATORY SYNDROME;
THAILAND;
VIET NAM;
WORLD HEALTH ORGANIZATION;
IMMUNOLOGY;
PHASE 3 CLINICAL TRIAL (TOPIC);
CLINICAL TRIALS, PHASE III AS TOPIC;
DENGUE;
DENGUE VACCINES;
HUMANS;
|
|
EID: 84930241483
PISSN: 21645515
EISSN: 2164554X
Source Type: Journal
DOI: 10.4161/hv.32075 Document Type: Note |
|
Times cited : (1)
|
|
References (2)
|
